View Older Stories View More Recent Stories

Feb 19, 2020 04:05PM Ironwood Pharmaceuticals to Present at SVB Leerink Global Healthcare Conference
Feb 13, 2020 07:00AM Ironwood Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2019 Results, Exceeding Full Year 2019 Guidance; Provides Full Year 2020 Guidance
Jan 30, 2020 04:05PM Ironwood Pharmaceuticals to Host Fourth Quarter and Full Year 2019 Investor Update Call
Jan 22, 2020 09:21AM Ironwood Pharma (IRWD), Allergan (AGN) Settle LINZESS (linaclotide) Patent Litigation with Teva (TEVA)
Jan 22, 2020 09:20AM Ironwood and Allergan Announce Settlement with Teva Resolving LINZESS® (linaclotide) Patent Litigation
Jan 6, 2020 08:10AM Ironwood Pharma (IRWD), Allergan (AGN) Announce Settlement Resolving LINZESS Patent Litigation
Jan 6, 2020 08:00AM Ironwood and Allergan Announce Settlement Resolving LINZESS® (linaclotide) Patent Litigation
Jan 2, 2020 04:01PM Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Nov 13, 2019 04:05PM Dermira Elects Halley E. Gilbert to its Board of Directors
Nov 5, 2019 04:05PM Ironwood Pharmaceuticals to Present at the 28th Annual Credit Suisse Healthcare Conference
Oct 31, 2019 07:00AM Ironwood Pharmaceuticals Reports Third Quarter 2019 Results; Raises Full Year 2019 Guidance
Oct 28, 2019 08:00AM Ironwood Pharmaceuticals to Highlight New Data at the American College of Gastroenterology 2019 Annual Scientific Meeting
Oct 17, 2019 04:05PM Ironwood Pharmaceuticals to Host Third Quarter 2019 Investor Update Call
Sep 18, 2019 06:22AM Ironwood Pharma (IRWD), AstraZeneca (AZN) Collaborate in China on LINZESS
Sep 18, 2019 02:00AM Ironwood Pharmaceuticals and AstraZeneca Amend LINZESS® (linaclotide) Collaboration in China
Aug 28, 2019 04:05PM Ironwood Pharmaceuticals to Present at Upcoming September Investor Conferences
Aug 13, 2019 07:31AM Ironwood (IRWD), Alnylam Pharma (ALNY) Enter U.S. GI Disease Education and Promotional Agreement for Alnylam's Givosiran in AHP
Aug 13, 2019 07:30AM Alnylam Pharmaceuticals and Ironwood Pharmaceuticals Enter U.S. GI Disease Education and Promotional Agreement for Alnylam’s Givosiran in Acute Hepatic Porphyria (AHP)
Aug 13, 2019 07:30AM Ironwood Pharmaceuticals and Alnylam Pharmaceuticals Enter U.S. GI Disease Education and Promotional Agreement for Alnylam’s Givosiran in Acute Hepatic Porphyria (AHP)
Jul 30, 2019 04:01PM Ironwood Pharmaceuticals Reports Second Quarter 2019 Results
Jul 18, 2019 04:05PM Ironwood Pharmaceuticals to Host Second Quarter 2019 Investor Update Call
Jun 18, 2019 04:09PM Ironwood Pharma (IRWD), Allergan (AGN) Announce Positive Topline Data from Phase IIIb Trial of LINZESS (linaclotide) in Adults with IBS-C
Jun 18, 2019 04:05PM Ironwood and Allergan Report Positive Topline Data from Phase IIIb Trial of LINZESS® (linaclotide) in Adults with Irritable Bowel Syndrome with Constipation (IBS-C)
Jun 13, 2019 04:30PM Ironwood Pharmaceuticals to Establish New Headquarters in Downtown Boston
Jun 3, 2019 08:33AM Ironwood Pharma (IRWD), Allergen (AGN) Commence Patient Dosing in Phase II Clinical Trial of MD-7246 in Patients with Abdominal Pain Associated with IBS-D
Jun 3, 2019 08:30AM Ironwood Pharmaceuticals and Allergan Initiate Patient Dosing in Phase II Clinical Trial of MD-7246 in Patients with Abdominal Pain Associated with IBS-D
May 9, 2019 08:00AM Ironwood Pharmaceuticals to Highlight IW-3718 and Linaclotide Data at Digestive Disease Week® 2019
May 7, 2019 04:05PM Ironwood Pharmaceuticals to Present at the 2019 Bank of America Merrill Lynch Healthcare Conference
May 2, 2019 07:00AM Ironwood Pharmaceuticals Reports First Quarter 2019 Results; Announces Positive 2019 Adjusted EBITDA from Continuing Operations Guidance
Apr 18, 2019 04:05PM Ironwood Pharmaceuticals to Host First Quarter 2019 Investor Update Call
Apr 16, 2019 04:02PM Ironwood Pharmaceuticals Announces Adjustment of Conversion Rate for its 2.25% Convertible Senior Notes due 2020
Apr 1, 2019 04:02PM Ironwood Pharmaceuticals Completes Separation of Cyclerion Therapeutics and Becomes a Gastrointestinal (GI)-focused Healthcare Company
Mar 14, 2019 04:54PM Ironwood Announces Effectiveness of Cyclerion Form 10 Registration Statement
Mar 7, 2019 04:05PM Ironwood Pharmaceuticals to Present at Barclays Global Healthcare Conference
Mar 4, 2019 04:05PM Ironwood Pharmaceuticals to Present at Cowen Health Care Conference
Feb 26, 2019 09:00AM Cyclerion, the Planned R&D Spin-off of Ironwood Pharmaceuticals, Secures Commitments of $175 Million in Private Offering
Feb 21, 2019 04:05PM Ironwood Pharmaceuticals to Present at SVB Leerink Global Healthcare Conference
Feb 13, 2019 07:00AM Ironwood Pharmaceuticals Provides Fourth Quarter and Full Year 2018 Investor Update
Jan 28, 2019 05:00PM Ironwood Pharmaceuticals to Host Fourth Quarter and Full-Year 2018 Investor Update Call
Jan 28, 2019 08:30AM Ironwood Announces Filing of Form 10 Registration Statement in Connection with Planned Business Separation
Jan 24, 2019 08:00AM Ironwood Pharmaceuticals Announces Board of Directors for Ironwood and Cyclerion, Effective Following Separation
Jan 23, 2019 04:01PM Ironwood Pharma (IRWD) Begins Phase 1 Trial of IW-6463
Jan 23, 2019 04:01PM Ironwood Pharmaceuticals Initiates Phase 1 Trial of IW-6463, the First CNS-penetrant sGC Stimulator to Enter Clinical Trials
Jan 15, 2019 08:05AM Ironwood Pharma (IRWD) Announces Approval of LINZESS in China for Treatment of Adults with IBS-C
Jan 15, 2019 08:00AM Ironwood Pharmaceuticals Announces Approval of LINZESS® (linaclotide) in China for the Treatment of Adults with IBS-C
Jan 6, 2019 05:00PM Ironwood Pharmaceuticals Appoints Michael Shetzline, M.D., Ph.D. as Chief Medical Officer
Jan 4, 2019 12:08PM Ironwood Pharma (IRWD) Confirms Mark Mallon as New CEO
Jan 4, 2019 12:05PM Ironwood Pharmaceuticals Announces Chief Executive Officers to Lead Ironwood and Cyclerion, Effective Upon Upcoming Separation
Jan 2, 2019 05:00PM Ironwood Pharmaceuticals to Present at J.P. Morgan Healthcare Conference
Jan 2, 2019 04:03PM Ironwood and Allergan Announce Settlement with Mylan Resolving LINZESS® (linaclotide) Patent Litigation
View More Recent Stories View Older Stories